Adelaide Research & Scholarship: Search

Search

Results 1-5 of 5 (Search time: 0.002 seconds).

previous
1
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2016	Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation	Hijazi, Z.; Aulin, J.; Andersson, U.; Alexander, J.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Hylek, E.; Lopes, R.; Siegbahn, A.; Wallentin, L.
	2010	Apixaban for reduction in stroke and other ThromboemboLic events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale	Lopes, R.; Alexander, J.; Al-Khatib, S.; Ansell, J.; Diaz, R.; Easton, J.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Hylek, E.; McMurray, J.; Verheugt, F.; Wallentin, L.
	2012	Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial	Lopes, R.; Al-Khatib, S.; Wallentin, L.; Yang, H.; Ansell, J.; Bahit, M.; De Caterina, R.; Dorian, P.; Easton, J.; Erol, C.; Ezekowitz, J.; Gersh, B.; Granger, C.; Hohnloser, S.; Horowitz, J.; Hylek, E.; McMurray, J.; Mohan, P.; Vinereanu, D.; Alexander, J.
	2014	High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin	Hijazi, Z.; Wallentin, L.; Siegbahn, A.; Andersson, U.; Alexander, J.; Atar, D.; Gersh, B.; Hanna, M.; Harjola, V.; Horowitz, J.; Husted, S.; Hylek, E.; Lopes, R.; McMurray, J.; Granger, C.
	2014	Response to letter regarding article, "efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation"	Wallentin, L.; Lopes, R.D.; Hanna, M.; Thomas, L.; Hellkamp, A.; Nepal, S.; Hylek, E.M.; Al-Khatib, S.M.; Alexander, J.H.; Alings, M.; Amerena, J.; Ansell, J.; Aylward, P.; Bartunek, J.; Commerford, P.; De Caterina, R.; Erol, C.; Harjola, V.P.; Held, C.; Horowitz, J.; et al.